How Evogene is changing the future for the pharma and agriculture markets
AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology
AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology
The collaboration will use Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.
Some are barely into their twenties, yet they decide which startups receive funding. Inside Ben-Gurion University's Cactus Capital, students aren't preparing to become investors. They already are.
Meet Stratos Ventures, the new Israeli fund connecting homeland security, government cyber, and supply chains with the strongest minds in the US.
The Amy Group, owned by businessman Shlomi Nechaisi, continues to expand in the cinema sector and is acquiring the Planet complex in Rishon Lezion.
An Israeli from Los Angeles is accused of a massive fraud: He recruited elderly people to nursing hospitals, paid bribes – and even registered deceased people for hospice after their death.
A 31 percent plunge in SpaceX stock from its peak and new restrictions on Tesla shares valued at $116 billion wiped hundreds of billions from Musk's fortune.
Snyk was founded by Israelis in the UK and the US, and in 2020 operated a development center in Israel with several hundred employees
Drama in the tobacco market with the loss of a giant contract for the distribution company Globrands: It loses a line of strong brands responsible for nearly half of its revenues.
Tower's share price has jumped nearly 900% in the past five years, but less than 24 hours after reaching the top, the world's chip stocks plummeted, and Tower's share price tumbled 10.79%